Table 3 Multivariate linear regression: significant factors of PP amplification in the different women groups of the study

Overall study population

≤55 years

R² model = 0.11

Term

Partial r²

Coefficient (CI)

P value

HbA1c

0.04

0.03 [0.02; 0.04]

0.04

Dyslipidemia (no)

−0.01 [−0.06; 0.04]

0.68

>55 years

R² model = 0.14

Term

Partial r²

Coefficient (CI)

P value

HbA1c

0.04

0.05 [0.04; 0.06]

0.0002

Mean BP

−0.002 [−0.004; 0.001]

0.13

CAD

−0.02 [−0.06; 0.02]

0.52

Kaliuresis

−0.0006 [0.002; 0.0002]

0.38

Hypertensive diabetic patients

≤55 years

R² model = 0.43

Term

Partial r²

Coefficient (CI)

P value

HbA1c

0.20

0.02 [0.01; 0.03]

0.04

cGFR ( < 60)

−0.04 [−0.06; 0.01]

0.49

Mean BP

−0.002 [−0.006; 0.001]

0.13

Height

0.009 [−0.002; 0.01]

0.35

>55 years

R² model = 0.21

Term

Partial r²

Coefficient (CI)

P value

cGFR ( < 60)

0.08

−0.03 [−0.06; −0.02]

0.04

Mean BP

−0.003 [−0.006; 0.001]

0.28

Height

0.002 [−0.001; 0.005]

0.64

Dyslipidemia (no)

−0.01[−0.03; 0.02]

0.54

Atherosclerosis (no)

−0.02 [−0.04; 0.05]

0.57

Hypertensive nondiabetic patients

≤55 years

R² model = 0.19

Term

Partial r²

Coefficient (CI)

P value

Mean BP

0.12

−0.0001 [−0.002; −0.00001]

0.04

Preious CV events (no)

−0.08 [−0.27; 0.02]

0.33

Atherosclerosis (no)

0.04 [−0.05; 0.14]

0.88

>55 years

R² model = 0.13

Term

Partial r²

Coefficient (CI)

P value

cGFR ( < 60)

0.10

−0.05 [−0.08; -0.01]

0.04

Previous CV events (no)

−0.03 [−0.06; 0.02]

0.28

Mean BP

−0.001 [−0.02; 0.01]

0.31